Clinical Trial Update: Epidemiology Study of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)

View source ↗

Summary

A completed epidemiology study on non-arteritic anterior ischemic optic neuropathy (NAION) with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Optic Neuropathy
• Non-arteritic Anterior Ischemic Optic Neuropathy

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Anterior Ischemic Optic Neuropathy, Ischemic Optic Neuropathy | Status: COMPLETED | Results posted: 2011-04-25